CELU Financials

Income Statement
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Revenue
4.1M
-22.3%
5.3M
-7.9%
5.7M
-49.8%
11.4M
-37.0%
18.1M
Cost of Revenue
7.4M
+88.9%
3.9M
-25.5%
5.2M
+47.5%
3.6M
-51.6%
7.3M
Gross Profit
-3270000
-337.0%
1.4M
+179.4%
494.0K
-93.7%
7.9M
-27.0%
10.8M
Operating Expenses
18.8M
+31.6%
14.3M
-12.7%
16.4M
-10.9%
18.4M
-8.5%
20.1M
R&D
3.3M
-27.2%
4.6M
+37.2%
3.4M
-10.1%
3.7M
-2.6%
3.8M
SG&A
15.1M
+61.9%
9.3M
-26.3%
12.6M
-11.4%
14.3M
-11.2%
16.1M
Operating Income
-22058000
-71.0%
-12900000
+18.7%
-15864000
-51.3%
-10486000
-13.0%
-9280000
EBITDA
-20204000
-81.6%
-11127000
+20.7%
-14030000
-62.2%
-8652000
-13.9%
-7597000
Net Income
-24362000
-5.6%
-23076000
+5.9%
-24524000
-24.1%
-19754000
-48.6%
-13293000
EPS (Basic)
$-0.86
+2.3%
$-0.88
+13.7%
$-1.02
-21.4%
$-0.84
-40.0%
$-0.60
EPS (Diluted)
$-0.86
+2.3%
$-0.88
+13.7%
$-1.02
-21.4%
$-0.84
-40.0%
$-0.60
Shares (Diluted)
28.5M
+8.2%
26.3M
+9.7%
24.0M
+2.1%
23.5M
+5.5%
22.3M
Celularity (CELU) โ€” Financials